FDA
-
-
-
-
-
-
-
Kindred Biosciences (KIN) Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel Disease
-
-
-
-
-
-
-
Kindred Biosciences Announces Second Quarter 2020 Financial Results
-
-
-
-
-
-
-
Kindred Biosciences (KIN) Reports Positive Results from Pilot Field Efficacy Study of IL-4/IL-13 SINK Molecule
-
-
-
-
-
-
-
Kindred Biosciences Announces First Quarter 2019 Financial Results
-
-
-
-
-
-
-
Kindred Biosciences Announces Positive Results from Pilot Effectiveness Study of its Fully Caninized IL-31 Antibody for the Treatment of Atopic Dermatitis in Dogs and Issuance of U.S. Patent
-
-
-
-
-
-
-
Kindred Biosciences Receives FDA Approval of Mirataz™ (mirtazapine transdermal ointment) for the Management of Weight Loss in Cats
-
-
-
-
-
-
-
Kindred Biosciences Announces Second Quarter 2017 Financial Results
-
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

